Thus, we showed here the tight co-localization and interaction patterns between FGFR2 and CLDN1 in IM-resistant GIST, which acquired its resistance to this RTKi due to activation of the FGFR-signaling pathway [12]. Here, CLDN1 is linked to gastrointestinal stromal tumor.